Last 12 months
Inside the activity.
5 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 5 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 29, 2019 Filed Apr 2, 2019 22:59 UTC |
Miller Franklin JDirector
|
SaleCommon Stock, No Par Value | 5,000 | $61.38 | $306,875.00 |
DisclosureSEC source: 0000856982-19-000040 · wf-form4_155424596597165.xml · nonDerivative · entry 3 Miller Franklin J · CIK 0001327767 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,038 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.25 to $61.42, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 22:59 UTC |
Miller Franklin JDirector
|
Exercise / conversionCommon Stock, No Par Value | 5,000 | $9.95 | $49,750.00 |
DisclosureSEC source: 0000856982-19-000040 · wf-form4_155424596597165.xml · nonDerivative · entry 2 Miller Franklin J · CIK 0001327767 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,038 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 28, 2019 Filed Mar 29, 2019 01:00 UTC |
STANGER KENT WDirector
|
SaleCommon Stock, No Par Value | 2,883 | $60.19 | $173,516.81 |
DisclosureSEC source: 0000856982-19-000037 · wf-form4_155382123519632.xml · nonDerivative · entry 6 STANGER KENT W · CIK 0000901531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 427,315 F6 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.33, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| March 27, 2019 Filed Mar 29, 2019 01:00 UTC |
STANGER KENT WDirector
|
SaleCommon Stock, No Par Value | 901 | $60.54 | $54,548.07 |
DisclosureSEC source: 0000856982-19-000037 · wf-form4_155382123519632.xml · nonDerivative · entry 5 STANGER KENT W · CIK 0000901531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 430,198 F5 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.51 to $60.59, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| March 26, 2019 Filed Mar 29, 2019 01:00 UTC |
STANGER KENT WDirector
|
SaleCommon Stock, No Par Value | 1,216 | $60.54 | $73,618.22 |
DisclosureSEC source: 0000856982-19-000037 · wf-form4_155382123519632.xml · nonDerivative · entry 4 STANGER KENT W · CIK 0000901531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 431,099 F4 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.50 to $60.58, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 22:13 UTC |
Miller Franklin JDirector
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 20,000 | $0.00 Strike: $12.91 | $0.00 |
DisclosureSEC source: 0000856982-19-000035 · wf-form4_155268799442955.xml · derivative · entry 4 Miller Franklin J · CIK 0001327767 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2019-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 05/23/2013. Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 22:13 UTC |
Miller Franklin JDirector
|
SaleCommon Stock, No Par Value | 20,000 | $60.44 | $1,208,760.00 |
DisclosureSEC source: 0000856982-19-000035 · wf-form4_155268799442955.xml · nonDerivative · entry 3 Miller Franklin J · CIK 0001327767 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,038 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.25 to $60.73, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 22:13 UTC |
Miller Franklin JDirector
|
Exercise / conversionCommon Stock, No Par Value | 20,000 | $12.91 | $258,200.00 |
DisclosureSEC source: 0000856982-19-000035 · wf-form4_155268799442955.xml · nonDerivative · entry 2 Miller Franklin J · CIK 0001327767 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,038 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 22:10 UTC |
Parra Raul Jr.Chief Financial Officer
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 1,000 | $0.00 Strike: $16.05 | $0.00 |
DisclosureSEC source: 0000856982-19-000034 · wf-form4_155268782810754.xml · derivative · entry 9 Parra Raul Jr. · CIK 0001742555 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 1,000 shares Expires 2023-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 01/28/2017. Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 22:10 UTC |
Parra Raul Jr.Chief Financial Officer
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 1,000 | $0.00 Strike: $17.27 | $0.00 |
DisclosureSEC source: 0000856982-19-000034 · wf-form4_155268782810754.xml · derivative · entry 8 Parra Raul Jr. · CIK 0001742555 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 1,000 shares Expires 2022-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 02/03/2016. Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 22:10 UTC |
Parra Raul Jr.Chief Financial Officer
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 1,000 | $0.00 Strike: $12.06 | $0.00 |
DisclosureSEC source: 0000856982-19-000034 · wf-form4_155268782810754.xml · derivative · entry 7 Parra Raul Jr. · CIK 0001742555 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 1,000 shares Expires 2021-10-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 10/04/2015. Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 22:10 UTC |
Parra Raul Jr.Chief Financial Officer
|
SaleCommon Stock, No Par Value | 5,000 | $60.20 | $301,020.00 |
DisclosureSEC source: 0000856982-19-000034 · wf-form4_155268782810754.xml · nonDerivative · entry 6 Parra Raul Jr. · CIK 0001742555 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The Reporting Person's sale of Merit Medical Systems, Inc.'s Common Stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 180 shares, with the Reporting Person's purchase of 180 shares of Merit Medical Systems, Inc.'s common stock at a price of $59.64 per share on March 13, 2019. The Reporting Person paid Merit Medical Systems, Inc. $96.57, representing the full amount of the profit realized in connection with the short-swing transaction, less transaction costs. F2 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.20 to $60.25, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 22:10 UTC |
Parra Raul Jr.Chief Financial Officer
|
Exercise / conversionCommon Stock, No Par Value | 2,000 | $44.80 | $89,600.00 |
DisclosureSEC source: 0000856982-19-000034 · wf-form4_155268782810754.xml · nonDerivative · entry 5 Parra Raul Jr. · CIK 0001742555 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 22:10 UTC |
Parra Raul Jr.Chief Financial Officer
|
Exercise / conversionCommon Stock, No Par Value | 1,000 | $16.05 | $16,050.00 |
DisclosureSEC source: 0000856982-19-000034 · wf-form4_155268782810754.xml · nonDerivative · entry 4 Parra Raul Jr. · CIK 0001742555 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 22:10 UTC |
Parra Raul Jr.Chief Financial Officer
|
Exercise / conversionCommon Stock, No Par Value | 1,000 | $17.27 | $17,270.00 |
DisclosureSEC source: 0000856982-19-000034 · wf-form4_155268782810754.xml · nonDerivative · entry 3 Parra Raul Jr. · CIK 0001742555 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 22:10 UTC |
Parra Raul Jr.Chief Financial Officer
|
Exercise / conversionCommon Stock, No Par Value | 1,000 | $12.06 | $12,060.00 |
DisclosureSEC source: 0000856982-19-000034 · wf-form4_155268782810754.xml · nonDerivative · entry 2 Parra Raul Jr. · CIK 0001742555 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 22:10 UTC |
Parra Raul Jr.Chief Financial Officer
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 2,000 | $0.00 Strike: $44.80 | $0.00 |
DisclosureSEC source: 0000856982-19-000034 · wf-form4_155268782810754.xml · derivative · entry 11 Parra Raul Jr. · CIK 0001742555 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 2,000 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 03/02/2019. Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 22:10 UTC |
Parra Raul Jr.Chief Financial Officer
|
OtherCommon Stock, No Par Value | 180 | $59.64 | $10,735.20 |
DisclosureSEC source: 0000856982-19-000034 · wf-form4_155268782810754.xml · nonDerivative · entry 1 Parra Raul Jr. · CIK 0001742555 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By 401 (k) plan Disclosed balance after: 463 Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 00:00 UTC |
STILLABOWER MICHAEL EDirector
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 20,000 | $0.00 Strike: $12.91 | $0.00 |
DisclosureSEC source: 0000856982-19-000029 · wf-form4_155183040338058.xml · derivative · entry 3 STILLABOWER MICHAEL E · CIK 0001192955 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2019-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 05/23/2013. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 00:00 UTC |
STILLABOWER MICHAEL EDirector
|
SaleCommon Stock, No Par Value | 10,000 | $58.05 | $580,529.00 |
DisclosureSEC source: 0000856982-19-000029 · wf-form4_155183040338058.xml · nonDerivative · entry 2 STILLABOWER MICHAEL E · CIK 0001192955 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,618 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.000 to $58.105, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 00:00 UTC |
STILLABOWER MICHAEL EDirector
|
Exercise / conversionCommon Stock, No Par Value | 20,000 | $12.91 | $258,200.00 |
DisclosureSEC source: 0000856982-19-000029 · wf-form4_155183040338058.xml · nonDerivative · entry 1 STILLABOWER MICHAEL E · CIK 0001192955 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,618 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 23:54 UTC |
Lampropoulos Fred P.Director · President & CEO
|
GrantNon-qualified stock options (right to buy) · Derivative | 159,151 | $0.00 Strike: $55.73 | $0.00 |
DisclosureSEC source: 0000856982-19-000027 · wf-form4_155183008371557.xml · derivative · entry 15 LAMPROPOULOS FRED P · CIK 0000901534 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,151 Underlying: Common Stock · 159,151 shares Expires 2026-03-01 F8 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 3/1/2020. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 23:54 UTC |
Lampropoulos Fred P.Director · President & CEO
|
GrantNon-qualified stock options (right to buy) · Derivative | 10,000 | $0.00 Strike: $55.73 | $0.00 |
DisclosureSEC source: 0000856982-19-000027 · wf-form4_155183008371557.xml · derivative · entry 14 LAMPROPOULOS FRED P · CIK 0000901534 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Please refer to footnote number four. Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2026-03-01 F8 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 3/1/2020. F4 · ownership.nature: Represents derivative securities held by the spouse of the reporting person. The reporting person expressly disclaims beneficial ownership of the securities owned by his spouse. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 23:51 UTC |
Lloyd Brian G.Chief Legal Officer, Secretary
|
GrantNon-qualified stock options (right to buy) · Derivative | 30,000 | $0.00 Strike: $55.73 | $0.00 |
DisclosureSEC source: 0000856982-19-000026 · wf-form4_155182985438927.xml · derivative · entry 5 Lloyd Brian G. · CIK 0001671772 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2026-03-01 F5 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing on 03/01/2020. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 23:47 UTC |
Parra Raul Jr.Chief Financial Officer
|
GrantNon-qualified stock options (right to buy) · Derivative | 30,000 | $0.00 Strike: $55.73 | $0.00 |
DisclosureSEC source: 0000856982-19-000025 · wf-form4_155182963623408.xml · derivative · entry 7 Parra Raul Jr. · CIK 0001742555 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2026-03-01 F6 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing on 03/01/2020. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 23:44 UTC |
Lampropoulos Justin J.EVP GLOBAL SALES, MKTG & STGY
|
GrantNon-qualified stock options (right to buy) · Derivative | 30,000 | $0.00 Strike: $55.73 | $0.00 |
DisclosureSEC source: 0000856982-19-000024 · wf-form4_155182943419997.xml · derivative · entry 7 Lampropoulos Justin J. · CIK 0001643609 · EVP GLOBAL SALES, MKTG & STGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2026-03-01 F7 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing on 03/01/2020. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 23:41 UTC |
Frost RonaldChief Operating Officer
|
GrantNon-qualified stock options (right to buy) · Derivative | 30,000 | $0.00 Strike: $55.73 | $0.00 |
DisclosureSEC source: 0000856982-19-000023 · wf-form4_155182930364882.xml · derivative · entry 7 Frost Ronald · CIK 0001595939 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2026-03-01 F7 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 03/01/2020. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 23:39 UTC |
Wright JosephPresident, International
|
GrantNon-qualified stock options (right to buy) · Derivative | 30,000 | $0.00 Strike: $55.73 | $0.00 |
DisclosureSEC source: 0000856982-19-000022 · wf-form4_155182915512144.xml · derivative · entry 7 Wright Joseph · CIK 0001643713 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2026-03-01 F7 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing on 03/01/2020. Read SEC document |
| January 07, 2019 Filed Jan 10, 2019 22:38 UTC |
HUEBNER ELIZABETHDirector
|
GrantNon-qualified stock options (right to buy) · Derivative | 9,726 | $0.00 Strike: $51.31 | $0.00 |
DisclosureSEC source: 0000856982-19-000008 · wf-form4_154715992084428.xml · derivative · entry 1 HUEBNER ELIZABETH · CIK 0001136845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,726 Underlying: Common Stock · 9,726 shares Expires 2026-01-07 F1 · derivative.exercise_date: Becomes exercisable in equal annual installments of 33% commencing 01/07/2020. Read SEC document |
| January 07, 2019 Filed Jan 10, 2019 22:31 UTC |
Anderson JillDirector
|
GrantNon-qualified stock options (right to buy) · Derivative | 9,726 | $0.00 Strike: $51.31 | $0.00 |
DisclosureSEC source: 0000856982-19-000007 · wf-form4_154715948694539.xml · derivative · entry 1 Anderson Jill · CIK 0001764314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,726 Underlying: Common Stock · 9,726 shares Expires 2026-01-07 F1 · derivative.exercise_date: Becomes exercisable in equal annual installments of 33% commencing 01/07/2020. Read SEC document |
| December 28, 2018 Filed Feb 13, 2019 17:23 UTC |
STANGER KENT WDirector
|
GiftCommon Stock, No Par Value | 350 | $0.00 | $0.00 |
DisclosureSEC source: 0000856982-19-000010 · wf-form5_155007860090520.xml · nonDerivative · entry 5 STANGER KENT W · CIK 0000901531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 432,315 F4 · price: This is a gift. Read SEC document |
| November 29, 2018 Filed Dec 3, 2018 21:56 UTC |
Karras Nolan E.Director
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 3,000 | $0.00 Strike: $9.95 | $0.00 |
DisclosureSEC source: 0000856982-18-000090 · wf-form4_154387414669726.xml · derivative · entry 5 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 3,000 shares Expires 2020-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 5/22/2014. Read SEC document |
| November 29, 2018 Filed Dec 3, 2018 21:56 UTC |
Karras Nolan E.Director
|
SaleCommon Stock, No Par Value | 2,000 | $61.28 | $122,550.00 |
DisclosureSEC source: 0000856982-18-000090 · wf-form4_154387414669726.xml · nonDerivative · entry 4 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 F2 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.25 to $61.30, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F1 · ownership.direct: Shares held jointly by the reporting person and his spouse. Read SEC document |
| November 29, 2018 Filed Dec 3, 2018 21:56 UTC |
Karras Nolan E.Director
|
Exercise / conversionCommon Stock, No Par Value | 3,000 | $9.95 | $29,850.00 |
DisclosureSEC source: 0000856982-18-000090 · wf-form4_154387414669726.xml · nonDerivative · entry 3 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.direct: Shares held jointly by the reporting person and his spouse. Read SEC document |
| November 16, 2018 Filed Nov 20, 2018 20:25 UTC |
Frost RonaldChief Operating Officer
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 4,743 | $0.00 Strike: $13.14 | $0.00 |
DisclosureSEC source: 0000856982-18-000088 · wf-form4_154274550488992.xml · derivative · entry 4 Frost Ronald · CIK 0001595939 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,743 shares Expires 2020-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Became exercisable in equal annual installments of 20% commencing on 07/31/2014. Read SEC document |
| November 16, 2018 Filed Nov 20, 2018 20:25 UTC |
Frost RonaldChief Operating Officer
|
SaleCommon Stock, No Par Value | 4,743 | $61.30 | $290,745.90 |
DisclosureSEC source: 0000856982-18-000088 · wf-form4_154274550488992.xml · nonDerivative · entry 3 Frost Ronald · CIK 0001595939 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| November 16, 2018 Filed Nov 20, 2018 20:25 UTC |
Frost RonaldChief Operating Officer
|
Exercise / conversionCommon Stock, No Par Value | 4,743 | $13.14 | $62,323.02 |
DisclosureSEC source: 0000856982-18-000088 · wf-form4_154274550488992.xml · nonDerivative · entry 2 Frost Ronald · CIK 0001595939 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,743 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2018 Filed Nov 20, 2018 20:17 UTC |
Lampropoulos Justin J.EVP GLOBAL SALES, MKTG & STGY
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 20,000 | $0.00 Strike: $12.06 | $0.00 |
DisclosureSEC source: 0000856982-18-000086 · wf-form4_154274502775897.xml · derivative · entry 4 Lampropoulos Justin J. · CIK 0001643609 · EVP GLOBAL SALES, MKTG & STGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 20,000 shares Expires 2021-10-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing on 10/04/2015. Read SEC document |
| November 16, 2018 Filed Nov 20, 2018 20:17 UTC |
Lampropoulos Justin J.EVP GLOBAL SALES, MKTG & STGY
|
SaleCommon Stock, No Par Value | 20,000 | $61.01 | $1,220,200.00 |
DisclosureSEC source: 0000856982-18-000086 · wf-form4_154274502775897.xml · nonDerivative · entry 2 Lampropoulos Justin J. · CIK 0001643609 · EVP GLOBAL SALES, MKTG & STGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.155 to $61.400, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| November 16, 2018 Filed Nov 20, 2018 20:17 UTC |
Lampropoulos Justin J.EVP GLOBAL SALES, MKTG & STGY
|
Exercise / conversionCommon Stock, No Par Value | 20,000 | $12.06 | $241,200.00 |
DisclosureSEC source: 0000856982-18-000086 · wf-form4_154274502775897.xml · nonDerivative · entry 1 Lampropoulos Justin J. · CIK 0001643609 · EVP GLOBAL SALES, MKTG & STGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 23:14 UTC |
Frost RonaldChief Operating Officer
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 5,257 | $0.00 Strike: $13.14 | $0.00 |
DisclosureSEC source: 0000856982-18-000080 · wf-form4_154180528198661.xml · derivative · entry 4 Frost Ronald · CIK 0001595939 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,743 Underlying: Common Stock · 5,257 shares Expires 2020-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Became exercisable in equal annual installments of 20% commencing 07/31/2014. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 23:14 UTC |
Frost RonaldChief Operating Officer
|
SaleCommon Stock, No Par Value | 5,257 | $61.31 | $322,296.16 |
DisclosureSEC source: 0000856982-18-000080 · wf-form4_154180528198661.xml · nonDerivative · entry 3 Frost Ronald · CIK 0001595939 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.30 to $61.35, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 23:14 UTC |
Frost RonaldChief Operating Officer
|
Exercise / conversionCommon Stock, No Par Value | 5,257 | $13.14 | $69,076.98 |
DisclosureSEC source: 0000856982-18-000080 · wf-form4_154180528198661.xml · nonDerivative · entry 2 Frost Ronald · CIK 0001595939 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,257 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 21:36 UTC |
Millner F. Ann Ed.D.Director
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 5,000 | $0.00 Strike: $34.40 | $0.00 |
DisclosureSEC source: 0000856982-18-000074 · wf-form4_154119460030376.xml · derivative · entry 7 Millner F. Ann · CIK 0001649014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 5,000 shares Expires 2024-05-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 5/24/2018. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 21:36 UTC |
Millner F. Ann Ed.D.Director
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 5,000 | $0.00 Strike: $18.80 | $0.00 |
DisclosureSEC source: 0000856982-18-000074 · wf-form4_154119460030376.xml · derivative · entry 6 Millner F. Ann · CIK 0001649014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 5,000 shares Expires 2023-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 5/26/2017. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 21:36 UTC |
Millner F. Ann Ed.D.Director
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 4,247 | $0.00 Strike: $21.98 | $0.00 |
DisclosureSEC source: 0000856982-18-000074 · wf-form4_154119460030376.xml · derivative · entry 5 Millner F. Ann · CIK 0001649014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,492 Underlying: Common Stock · 4,247 shares Expires 2022-07-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 7/16/2016. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 21:36 UTC |
Millner F. Ann Ed.D.Director
|
SaleCommon Stock, No Par Value | 9,593 | $56.92 | $546,052.75 |
DisclosureSEC source: 0000856982-18-000074 · wf-form4_154119460030376.xml · nonDerivative · entry 4 Millner F. Ann · CIK 0001649014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,298 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.88 to $57.04, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 21:36 UTC |
Millner F. Ann Ed.D.Director
|
Exercise / conversionCommon Stock, No Par Value | 5,000 | $34.40 | $172,000.00 |
DisclosureSEC source: 0000856982-18-000074 · wf-form4_154119460030376.xml · nonDerivative · entry 3 Millner F. Ann · CIK 0001649014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,891 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 21:36 UTC |
Millner F. Ann Ed.D.Director
|
Exercise / conversionCommon Stock, No Par Value | 5,000 | $18.80 | $94,000.00 |
DisclosureSEC source: 0000856982-18-000074 · wf-form4_154119460030376.xml · nonDerivative · entry 2 Millner F. Ann · CIK 0001649014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,891 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 21:36 UTC |
Millner F. Ann Ed.D.Director
|
Exercise / conversionCommon Stock, No Par Value | 4,247 | $21.98 | $93,349.06 |
DisclosureSEC source: 0000856982-18-000074 · wf-form4_154119460030376.xml · nonDerivative · entry 1 Millner F. Ann · CIK 0001649014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,891 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.